Cargando…

Efficacy and safety of Everolimus in children with TSC - associated epilepsy – Pilot data from an open single-center prospective study

BACKGROUND: Epilepsy occurs in up to 90 % of all individuals with tuberous sclerosis complex (TSC). In 67 % disease onset is during childhood. In ≥ 50 % seizures are refractory to currently available treatment options. The mTOR-Inhibitor Everolimus (Votubia®) was approved for the treatment of subepe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samueli, Sharon, Abraham, Klaus, Dressler, Anastasia, Gröppel, Gudrun, Mühlebner-Fahrngruber, Angelika, Scholl, Theresa, Kasprian, Gregor, Laccone, Franco, Feucht, Martha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094073/ https://www.ncbi.nlm.nih.gov/pubmed/27809914 http://dx.doi.org/10.1186/s13023-016-0530-z

Ejemplares similares

Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy
por: Dressler, Anastasia, et al.
Publicado: (2017)

Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex
por: Scholl, Theresa, et al.
Publicado: (2017)

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015)

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
por: Bongaarts, Anika, et al.
Publicado: (2017)

Simpson-Golabi-Behmel-Syndrome in Dichorionic-Diamniotic Twin Pregnancy
por: Reischer, Theresa, et al.
Publicado: (2021)

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
por: Mühlebner, Angelika, et al.
Publicado: (2020)

Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)
por: Fuso, A., et al.
Publicado: (2016)

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017)

Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial
por: Franz, David N., et al.
Publicado: (2018)

Epilepsy and TSC-Associated Neuropsychiatric Disorders
por: Capal, Jamie K.
Publicado: (2020)

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
por: Overwater, Iris E, et al.
Publicado: (2019)

Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation
por: Perini, G F, et al.
Publicado: (2016)

Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression
por: Mühlebner, Angelika, et al.
Publicado: (2016)

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
por: Devarakonda, Siddhartha, et al.
Publicado: (2021)

Correlation between TSC1 gene polymorphism and epilepsy
por: Jiang, Xiuli, et al.
Publicado: (2017)

Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation
por: Hwang, Su-Kyeong, et al.
Publicado: (2016)

UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment
por: Wang, Zhan, et al.
Publicado: (2023)

LGG-49. Subependymal giant cell astrocytoma associated with a cortical tuber: A case report
por: Quinot, Valerie Anne, et al.
Publicado: (2022)

The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits
por: Hoogeveen-Westerveld, Marianne, et al.
Publicado: (2012)

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
por: Mühlebner, Angelika, et al.
Publicado: (2016)

LGG-18. EVEROLIMUS TREATMENT IN PEDIATRIC PATIENTS AFFECTED BY LOW-GRADE GLIOMAS (pLGG) NON-TSC, BRAF v600-WT
por: Cacchione, Antonella, et al.
Publicado: (2020)

Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
por: Grasl, S., et al.
Publicado: (2021)

Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
por: Moavero, Romina, et al.
Publicado: (2020)

Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
por: Tyburczy, Magdalena E., et al.
Publicado: (2015)

Evidence for population variation in TSC1 and TSC2 gene expression
por: Jentarra, Garilyn M, et al.
Publicado: (2011)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study
por: Wu, Joyce Y., et al.
Publicado: (2019)

Mosaic trisomy of chromosome 1q in human brain tissue associates with unilateral polymicrogyria, very early-onset focal epilepsy, and severe developmental delay
por: Kobow, Katja, et al.
Publicado: (2020)

Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies
por: Gruber, Victoria‐Elisabeth, et al.
Publicado: (2021)

Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions
por: Gruber, Victoria‐Elisabeth, et al.
Publicado: (2021)

Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas
por: Parry, L, et al.
Publicado: (2001)

Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2019)

Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results
por: Ruiz-Falcó Rojas, María Luz, et al.
Publicado: (2022)

Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients
por: Jiangyi, Wang, et al.
Publicado: (2020)

Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex
por: Li, Yi, et al.
Publicado: (2018)

Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex
por: Rosengren, Thomas, et al.
Publicado: (2020)

Correction: Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2020)

Ketogenic Diet in the Treatment of Super-Refractory Status Epilepticus at a Pediatric Intensive Care Unit: A Single-Center Experience
por: Breu, Markus, et al.
Publicado: (2021)

Functional characterisation of the TSC1–TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex
por: Nellist, Mark, et al.
Publicado: (2008)

Drosophila yakuba – Tsc1
por: Lose, Bailey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dpugqbqdod4gckl53vns1abmvm